{"disease":{"id":"high-grade-glioma-iii-or-iv","name":"high grade glioma iii or iv"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07455045","title":"A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06687681","title":"Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Marzieh Ebrahimi","has_results":false},{"nct_id":"NCT07210632","title":"Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":38,"lead_sponsor_name":"Eben Rosenthal","has_results":false},{"nct_id":"NCT04573140","title":"A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":28,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT02575794","title":"Terameprocol in Treating Patients With Recurrent High Grade Glioma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}